As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Shattuck Labs, a filing with the SEC revealed that on Wednesday, Chief Executive Officer Taylor Schreiber purchased 14,400 shares of STTK, at a cost of $3.47 each, for a total investment of $50,011. So far Schreiber is in the green, up about 27.3% on their buy based on today's trading high of $4.42. Shattuck Labs is trading up about 7.7% on the day Thursday.
And on Tuesday, Director Scott Juda purchased $36,350 worth of INmune Bio, purchasing 5,000 shares at a cost of $7.27 a piece. Before this latest buy, Juda made one other buy in the past twelve months, purchasing $246,297 shares for a cost of $8.32 a piece. INmune Bio is trading up about 7.4% on the day Thursday. Juda was up about 8.0% on the purchase at the high point of today's trading session, with INMB trading as high as $7.85 in trading on Thursday.
VIDEO: Thursday 6/27 Insider Buying Report: STTK, INMB
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
